Stocks closed solidly higher on Thursday for the fourth straight session as investor optimism about the Trump administration continues to run high.

US stocks showed mixed signals in premarket trading on Thursday. Futures for the S&P 500 lost 0.1% before the opening bell, ...

The benchmark S&P 500 rose to a record closing high on Thursday, as investors assessed a mixed bag of corporate earnings and ...

In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Elevance Health (ELV – Research Report) received a Buy rating and a $485.00 price target from Cantor Fitzgerald analyst Sarah James yesterday.

Elevance Health delivered earnings and 2025 guidance that broadly met analysts’ expectations, likely providing some relief to investors after a challenging quarter. The fourth-quarter results marked t ...

Sources: FactSet, Dow Jones Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet ...

For example, the March 2024 portfolio included several traditional value names such as alternative asset manager Carlyle Group CG and real estate firm Jones Lang LaSalle JLL. But it also held ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Trump's new focus on tech investment was questioned by his closest ally.